Literature DB >> 11723281

Onset of multiple sclerosis associated with anti-TNF therapy.

N L Sicotte1, R R Voskuhl.   

Abstract

Therapies aimed at inhibiting tumor necrosis factor (TNF), a proinflammatory cytokine implicated in autoimmune disease are effective, especially for rheumatoid arthritis. We report a patient with new onset MS closely associated with the initiation of anti-TNF therapy for juvenile rheumatoid arthritis. It is possible that the inhibition of TNF triggered MS in this individual.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11723281     DOI： 10.1212/wnl.57.10.1885

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


  84 in total

Review 1.  G protein-coupled receptors as therapeutic targets for multiple sclerosis.

Authors:  Changsheng Du; Xin Xie
Journal:  Cell Res       Date:  2012-06-05       Impact factor: 25.617

Review 2.  Management of chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  Richard A C Hughes
Journal:  Drugs       Date:  2003       Impact factor: 9.546

3.  Peripheral visual field loss following treatment with etanercept.

Authors:  L J Clifford; J D Rossiter
Journal:  Br J Ophthalmol       Date:  2004-06       Impact factor: 4.638

Review 4.  Anti-tumour necrosis factor alpha therapy in rheumatoid arthritis: an update on safety.

Authors:  K L Hyrich; A J Silman; K D Watson; D P M Symmons
Journal:  Ann Rheum Dis       Date:  2004-07-08       Impact factor: 19.103

5.  Neurological complications of biologic therapy in psoriasis: a review.

Authors:  Mark Bechtel; Catherine Sanders; Ann Bechtel
Journal:  J Clin Aesthet Dermatol       Date:  2009-11

Review 6.  [Biologics. New drugs, new adverse reactions].

Authors:  J C Prinz
Journal:  Hautarzt       Date:  2010-08       Impact factor: 0.751

7.  Monoclonal antibodies in multiple sclerosis treatment: current and future steps.

Authors:  Claire L Helliwell; Alasdair J Coles
Journal:  Ther Adv Neurol Disord       Date:  2009-07       Impact factor: 6.570

8.  A practical approach to screening psoriasis patients for therapy with biologic agents.

Authors: 
Journal:  J Clin Aesthet Dermatol       Date:  2008-09

Review 9.  Anti-tumor necrosis factor alpha-associated multiple sclerosis.

Authors:  David S Titelbaum; Alexandra Degenhardt; R Philip Kinkel
Journal:  AJNR Am J Neuroradiol       Date:  2005 Jun-Jul       Impact factor: 3.825

10.  Treatment of CNS sarcoidosis with infliximab and mycophenolate mofetil.

Authors:  Michael Moravan; Benjamin M Segal
Journal:  Neurology       Date:  2009-01-27       Impact factor: 9.910
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.